
Ionis Pharmaceuticals: 2024 Revenues Projected to Surpass Guidance due to Diverse Sales Sources, Forecasted at Over $600 Million
Ionis Pharmaceuticals Inc: Q4 Earnings Report and Its Implications On Wednesday, Ionis Pharmaceuticals Inc (IONS) reported its financial results for the fourth quarter of 2021. The biotech company recorded a GAAP (Generally Accepted Accounting Principles) earnings per share (EPS) loss of $0.66, which represents a significant increase from the loss of $0.06 reported in the…